Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

Conditions

• Multiple Sclerosis (MS)
• Neuromyelitis Optica Spectrum Disorder (NMOSD)
• Autoimmune Encephalitis (AE)
• Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• Myasthenia Gravis (MG)
• Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD)
• Idiopathic Inflammatory Myopathies (IIM)

Interventions

• BIOLOGICAL: Universal CD19 CAR-γδT Cell Injection
• DRUG: Cyclophosphamide
• DRUG: Fludarabine

Sponsor

Tongji Hospital